Bonus Episode: Targeted Topicals in Action: AD Patient Success Stories
In this roundtable discussion, Moderator Christopher Bunick, MD, PhD, an Associate Professor of Dermatology at Yale University and Director of The Bunick Lab at Yale in New Haven, CT, talks with Terry Faleye, MPAS, PA-C, a Physician Associate in Kingswood, TX, Andrew Mastro, MS, PA-C, a Physician Assistant in Chicago, IL, and Lisa Swanson, MD, a Pediatric Dermatologist in Boise, ID, about the growing role that advanced topical therapies such as ruxolitinib (Opzelura, Incyte) can, and should, play in atopic dermatitis (AD).
In this seven-episode arc, experts weigh in on ideal candidates for today’s targeted topicals, best practices for counseling patients and caregivers on their safety, the importance of combining clinician- and patient-reported outcomes that capture the full impact of the disease on quality of life, plus other key considerations when treating AD.